Compounded Testosterone Therapy: What to Know

Compounded Testosterone Therapy: What to Know

If your healthcare provider is discussing testosterone therapy with you, you may encounter both FDA-approved testosterone medications and compounded testosterone. Understanding the difference can help you ask informed questions about why a particular option is being considered.

Compounded testosterone is a prescription medication prepared for an individually identified patient based on a licensed provider’s prescription. Compounded medications are not FDA-approved. Unlike FDA-approved medications, compounded drugs do not undergo FDA premarket review for safety, effectiveness or quality.

Compounding can, however, serve an important role when a patient’s medically appropriate needs cannot be met by an FDA-approved medication. The decision to consider compounded testosterone should be individualized and made by a licensed provider based on the patient’s clinical needs.

What Is Compounded Testosterone Therapy?

Pharmaceutical compounding is the process of preparing a medication to meet the specific needs of an individual patient based on a prescriber-issued prescription.

In 503A pharmacy compounding, a licensed provider determines that a compounded medication is appropriate for an individually identified patient and issues a prescription. The pharmacy then prepares that prescription according to the prescriber’s directions and applicable compounding standards.

For testosterone compounding, this means the medication is prepared in response to an individual prescription. Compounded testosterone should not be viewed as a mass-produced alternative to commercially available testosterone medications.

It is also important to distinguish the medication itself from the broader treatment plan. Testosterone therapy requires medical evaluation and ongoing provider oversight whether an FDA-approved or compounded medication is prescribed.

Compounded Testosterone vs. FDA-Approved Testosterone: What’s the Difference?

The most important distinction involves FDA review.

FDA-approved testosterone medications have gone through the FDA’s drug approval process. That process evaluates evidence related to a medication’s safety, effectiveness and quality for its approved use.

Compounded testosterone medications do not go through FDA premarket approval. The FDA does not review or approve an individual compounded drug for safety, effectiveness or quality before it is dispensed.

“Compounded” also does not mean “generic.” FDA-approved generic medications must meet FDA requirements associated with the drug approval process. A compounded prescription is prepared for an individual patient based on a prescriber’s determination that compounding is medically appropriate.

These differences do not mean that compounded testosterone is inherently safer, more effective or better than an FDA-approved testosterone medication. Compounding serves a different purpose. It may be considered when an available FDA-approved medication cannot meet an individual patient’s medically appropriate needs.

When Might a Provider Consider Compounded Testosterone?

FDA-approved medications are generally considered before compounded alternatives when an appropriate approved option can meet a patient’s needs.

A licensed provider may consider patient-specific compounding when a commercially available medication does not meet an individual patient’s medically appropriate needs. Depending on the prescription and available compounding options, this could involve an individualized strength, dosage form or formulation adjustment when clinically appropriate.

The key question is not whether a medication can be customized. It is whether there is an individual clinical need for a compounded prescription.

That determination belongs with the licensed provider. A pharmacist can then work with the prescriber to prepare the patient-specific prescription when appropriate.

Does Compounded Testosterone Treat Any Symptom of Low T?

Symptoms alone do not determine whether testosterone therapy is appropriate.

Changes sometimes associated with low testosterone can have many potential causes. Experiencing fatigue, changes in sexual health, changes in mood or other concerns does not establish testosterone deficiency and does not by itself indicate that testosterone therapy is needed.

A healthcare provider can evaluate symptoms alongside appropriate laboratory testing, medical history and other clinical information.

If testosterone therapy is ultimately considered, the next question is which treatment option, if any, is appropriate. A compounded prescription should not be assumed to be necessary simply because testosterone therapy is being discussed.

What Should Be Evaluated Before Testosterone Therapy?

Testosterone therapy should begin with an individualized medical evaluation rather than a decision based on symptoms alone.

A provider may consider your symptoms, medical history, current medications and relevant health risks. Appropriate laboratory testing can also be part of determining whether testosterone therapy should be considered.

This evaluation matters because similar symptoms can have different causes. It also gives your provider an opportunity to discuss potential benefits and risks and determine whether additional evaluation is necessary.

If testosterone therapy is appropriate, your provider can then discuss available treatment options and whether an FDA-approved medication can meet your needs.

Does Compounded Testosterone Still Require Monitoring?

Yes. A compounded prescription does not eliminate the need for ongoing medical oversight.

Patients receiving testosterone therapy may require follow-up evaluation and monitoring based on the treatment plan and their individual health circumstances. Your provider determines what monitoring is appropriate and how frequently it should occur.

Monitoring also gives you an opportunity to discuss how you are using the medication, potential adverse effects, other health changes and whether the treatment plan remains appropriate.

Do not change your testosterone dose or stop therapy based on symptoms or laboratory results without discussing the change with your healthcare provider.

Questions to Ask Your Provider

If testosterone therapy is being discussed, understanding the reasoning behind the treatment plan can help you participate more actively in the decision.

Consider asking:

• Why is testosterone therapy being considered?
• Are FDA-approved testosterone options appropriate for me?
• Why is a compounded prescription being considered?
• What are the potential benefits and risks of testosterone therapy for me?
• What monitoring will I need?
• How should I use and store the prescribed medication?

If your provider recommends compounded testosterone, you can also ask what individual need the compounded prescription is intended to address.

How Pharmacists and Prescribers Collaborate

Patient-specific compounding involves collaboration between the prescriber, pharmacist and patient.

The licensed provider evaluates the patient and determines whether testosterone therapy is medically appropriate. If an FDA-approved medication does not meet that individual’s needs and compounding is clinically appropriate, the provider may issue a patient-specific prescription.

As a licensed 503A compounding pharmacy, Pharmacy Solutions can work with licensed prescribers to prepare compounded medications for individually identified patients according to their prescriptions. Pharmacy Solutions meets USP <797> and USP <800> standards and is accredited by the Pharmacy Compounding Accreditation Board.

The pharmacist can also help patients understand medication-specific administration, storage and dispensing-label instructions. Questions about whether testosterone therapy is medically appropriate, however, should remain part of the patient’s conversation with their healthcare provider.

Frequently Asked Questions About Compounded Testosterone

What is compounded testosterone?

Compounded testosterone is a prescription medication prepared by a compounding pharmacy for an individually identified patient based on a licensed provider’s prescription. It may be considered when a commercially available medication does not meet that patient’s medically appropriate needs.

Is compounded testosterone FDA-approved?

No. Compounded medications are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness or quality.

Why would a provider prescribe compounded testosterone?

A provider may consider a compounded prescription when an FDA-approved medication cannot meet an individual patient’s medically appropriate needs. The decision should be based on the patient’s clinical circumstances rather than an assumption that compounded medication is preferable.

Is compounded testosterone the same as TRT?

Testosterone replacement therapy, or TRT, refers broadly to testosterone therapy prescribed when medically appropriate. Compounded testosterone may be one prescription option considered within a testosterone treatment plan, but not all TRT involves compounded medication.

Is compounded testosterone safer than FDA-approved testosterone?

Compounded testosterone should not be described as inherently safer or more effective than an FDA-approved testosterone medication. The two categories differ in how they are prepared and regulated, including whether they have undergone FDA premarket approval.

Understand Why a Treatment Option Is Being Considered

If testosterone therapy is part of a conversation with your healthcare provider, understanding the reason behind each option matters. An FDA-approved testosterone medication may meet a patient’s needs, while patient-specific compounding may be considered in certain circumstances when an approved medication cannot.

Talk with your healthcare provider about which testosterone treatment options, if any, may be appropriate for your individual needs.